vs

Side-by-side financial comparison of ACACIA RESEARCH CORP (ACTG) and CODEXIS, INC. (CDXS). Click either name above to swap in a different company.

ACACIA RESEARCH CORP is the larger business by last-quarter revenue ($50.1M vs $38.9M, roughly 1.3× CODEXIS, INC.). CODEXIS, INC. runs the higher net margin — 24.7% vs 6.8%, a 17.9% gap on every dollar of revenue. On growth, CODEXIS, INC. posted the faster year-over-year revenue change (81.3% vs 2.6%). Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs 43.6%).

Acacia Research Corporation is a publicly traded American company based in New York City. It acquires and operates businesses in industries including the technology, energy, and industrial/manufacturing sectors. Acacia has a strategic relationship with Starboard Value, LP, the company's controlling shareholder. The company has been characterized as a patent troll.

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

ACTG vs CDXS — Head-to-Head

Bigger by revenue
ACTG
ACTG
1.3× larger
ACTG
$50.1M
$38.9M
CDXS
Growing faster (revenue YoY)
CDXS
CDXS
+78.7% gap
CDXS
81.3%
2.6%
ACTG
Higher net margin
CDXS
CDXS
17.9% more per $
CDXS
24.7%
6.8%
ACTG
Faster 2-yr revenue CAGR
CDXS
CDXS
Annualised
CDXS
51.0%
43.6%
ACTG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACTG
ACTG
CDXS
CDXS
Revenue
$50.1M
$38.9M
Net Profit
$3.4M
$9.6M
Gross Margin
12.8%
94.8%
Operating Margin
-26.1%
27.1%
Net Margin
6.8%
24.7%
Revenue YoY
2.6%
81.3%
Net Profit YoY
125.5%
192.5%
EPS (diluted)
$0.03
$0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACTG
ACTG
CDXS
CDXS
Q4 25
$50.1M
$38.9M
Q3 25
$59.4M
$8.6M
Q2 25
$51.2M
$15.3M
Q1 25
$124.4M
$7.5M
Q4 24
$48.8M
$21.5M
Q3 24
$23.3M
$12.8M
Q2 24
$25.8M
$8.0M
Q1 24
$24.3M
$17.1M
Net Profit
ACTG
ACTG
CDXS
CDXS
Q4 25
$3.4M
$9.6M
Q3 25
$-2.7M
$-19.6M
Q2 25
$-3.3M
$-13.3M
Q1 25
$24.3M
$-20.7M
Q4 24
$-13.4M
$-10.4M
Q3 24
$-14.0M
$-20.6M
Q2 24
$-8.4M
$-22.8M
Q1 24
$-186.0K
$-11.5M
Gross Margin
ACTG
ACTG
CDXS
CDXS
Q4 25
12.8%
94.8%
Q3 25
21.2%
71.3%
Q2 25
12.8%
86.3%
Q1 25
47.4%
63.8%
Q4 24
17.6%
83.0%
Q3 24
10.1%
66.4%
Q2 24
26.2%
56.6%
Q1 24
49.2%
71.6%
Operating Margin
ACTG
ACTG
CDXS
CDXS
Q4 25
-26.1%
27.1%
Q3 25
-10.8%
-220.3%
Q2 25
-24.2%
-83.9%
Q1 25
30.8%
-271.6%
Q4 24
-32.4%
-34.2%
Q3 24
-44.1%
-129.0%
Q2 24
-18.4%
-284.9%
Q1 24
-8.6%
-69.6%
Net Margin
ACTG
ACTG
CDXS
CDXS
Q4 25
6.8%
24.7%
Q3 25
-4.6%
-228.1%
Q2 25
-6.4%
-86.6%
Q1 25
19.5%
-274.3%
Q4 24
-27.5%
-48.4%
Q3 24
-60.0%
-160.8%
Q2 24
-32.7%
-285.2%
Q1 24
-0.8%
-67.4%
EPS (diluted)
ACTG
ACTG
CDXS
CDXS
Q4 25
$0.03
$0.13
Q3 25
$-0.03
$-0.22
Q2 25
$-0.03
$-0.16
Q1 25
$0.25
$-0.25
Q4 24
$-0.14
$-0.12
Q3 24
$-0.14
$-0.29
Q2 24
$-0.08
$-0.32
Q1 24
$0.00
$-0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACTG
ACTG
CDXS
CDXS
Cash + ST InvestmentsLiquidity on hand
$306.7M
$78.2M
Total DebtLower is stronger
$91.9M
$40.1M
Stockholders' EquityBook value
$543.5M
$50.5M
Total Assets
$771.0M
$147.8M
Debt / EquityLower = less leverage
0.17×
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACTG
ACTG
CDXS
CDXS
Q4 25
$306.7M
$78.2M
Q3 25
$301.8M
$58.7M
Q2 25
$316.7M
$66.3M
Q1 25
$272.0M
$59.8M
Q4 24
$273.9M
$73.5M
Q3 24
$410.9M
$90.3M
Q2 24
$441.9M
$73.2M
Q1 24
$498.4M
$85.5M
Total Debt
ACTG
ACTG
CDXS
CDXS
Q4 25
$91.9M
$40.1M
Q3 25
$39.7M
Q2 25
$39.4M
Q1 25
$29.2M
Q4 24
$28.9M
Q3 24
$28.6M
Q2 24
$28.4M
Q1 24
$28.1M
Stockholders' Equity
ACTG
ACTG
CDXS
CDXS
Q4 25
$543.5M
$50.5M
Q3 25
$537.6M
$38.5M
Q2 25
$538.6M
$55.6M
Q1 25
$540.2M
$49.6M
Q4 24
$514.8M
$66.9M
Q3 24
$540.2M
$73.4M
Q2 24
$560.7M
$61.4M
Q1 24
$568.3M
$79.3M
Total Assets
ACTG
ACTG
CDXS
CDXS
Q4 25
$771.0M
$147.8M
Q3 25
$768.9M
$124.0M
Q2 25
$775.5M
$138.2M
Q1 25
$801.6M
$128.9M
Q4 24
$756.4M
$149.0M
Q3 24
$707.6M
$148.2M
Q2 24
$753.6M
$132.0M
Q1 24
$631.7M
$149.6M
Debt / Equity
ACTG
ACTG
CDXS
CDXS
Q4 25
0.17×
0.79×
Q3 25
1.03×
Q2 25
0.71×
Q1 25
0.59×
Q4 24
0.43×
Q3 24
0.39×
Q2 24
0.46×
Q1 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACTG
ACTG
CDXS
CDXS
Operating Cash FlowLast quarter
$75.2M
$20.1M
Free Cash FlowOCF − Capex
$19.6M
FCF MarginFCF / Revenue
50.3%
Capex IntensityCapex / Revenue
1.3%
Cash ConversionOCF / Net Profit
22.01×
2.09×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACTG
ACTG
CDXS
CDXS
Q4 25
$75.2M
$20.1M
Q3 25
$9.5M
$-7.7M
Q2 25
$50.1M
$-18.0M
Q1 25
$2.4M
$-13.8M
Q4 24
$50.1M
$-16.5M
Q3 24
$-593.0K
$-13.0M
Q2 24
$16.1M
$-12.2M
Q1 24
$54.8M
$-7.8M
Free Cash Flow
ACTG
ACTG
CDXS
CDXS
Q4 25
$19.6M
Q3 25
$-7.9M
Q2 25
$-20.5M
Q1 25
$335.0K
$-15.1M
Q4 24
$-98.5M
$-18.2M
Q3 24
$-2.8M
$-14.0M
Q2 24
$-126.7M
$-12.6M
Q1 24
$54.6M
$-8.9M
FCF Margin
ACTG
ACTG
CDXS
CDXS
Q4 25
50.3%
Q3 25
-91.7%
Q2 25
-133.6%
Q1 25
0.3%
-199.6%
Q4 24
-201.8%
-85.0%
Q3 24
-12.1%
-109.0%
Q2 24
-490.5%
-157.5%
Q1 24
224.4%
-52.2%
Capex Intensity
ACTG
ACTG
CDXS
CDXS
Q4 25
1.3%
Q3 25
2.1%
Q2 25
16.4%
Q1 25
1.7%
16.7%
Q4 24
304.4%
8.3%
Q3 24
9.6%
7.8%
Q2 24
553.0%
5.0%
Q1 24
1.1%
6.6%
Cash Conversion
ACTG
ACTG
CDXS
CDXS
Q4 25
22.01×
2.09×
Q3 25
Q2 25
Q1 25
0.10×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACTG
ACTG

Energy Operations$16.0M32%
Transportation Safety$10.4M21%
Office Storage And Display Solutions$8.4M17%
Printers Consumables And Parts$6.5M13%
Natural Gas Reserves$5.1M10%
Natural Gas Liquids Reserves$3.3M7%

CDXS
CDXS

Segment breakdown not available.

Related Comparisons